Company Overview and News
SELECTED first overall in this season’s Philippine Basketball Association (PBA) rookie draft, Christian Standhardinger was expected to fortify what already is a solid San Miguel crew.
Notwithstanding the overall stock market slump, San Miguel Food and Beverage (FB) Inc. has attracted strong interest from potential cornerstone investors and is thus likely to attain $12-billion market capitalization during its upcoming follow-on stock offering.
SAN MIGUEL Food and Beverage, Inc. (SMFBI) — previously known as San Miguel Pure Foods Co., Inc. — is expected to generate P33 billion in earnings this year, once the beer, food, and liquor businesses are fully consolidated under its portfolio, according to sources.
San Miguel Corp. grew its first quarter recurring net income by 31 percent to P19.4 billion.
The following slide deck was published by San Miguel Corp. ADR in conjunction with their 2018 Q1 earnings call.
SAN MIGUEL CORP. (SMC) grew its consolidated recurring profit by a third in the first quarter of 2018, fueled by the performance of its liquor, beer, food, packaging, and fuel businesses.
San Miguel Corp. (SMC) plans to raise at least P10 billion through the sale of fixed-rate bonds, which will mainly be used to refinance debt and expand businesses.
SAN MIGUEL Corp. (SMC) looks to raise at least P10 billion from the issuance of fixed rate notes due 2020 to refinance existing debt and to manage dollar-denominated obligations.
Big business groups are eyeing Clark International Airport in Pampanga province, an air gateway north of Manila, which is significantly rising as an investment hub under the current administration.
San Miguel Corp. (SMC) looks to raise P10 billion from the issuance of fixed rate notes due 2020 fo refinancing existing debt and to manage dollar-denominated obligations.
Having covered the local sports beat for a while now and talked to many stakeholders, one thing stands out is the fact that much still needs to be done as far as the country’s sports program is concerned.
THE defending Philippine Basketball Association (PBA) Commissioner’s Cup champions San Miguel Beermen finally make their debut and they are doing it with a “big package” at hand in rookie Christian Standhardinger.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
SAN SALVADOR, El Salvador — A swarm of earthquakes shook southern El Salvador on Sunday, damaging nearly 200 homes and touching off small landslides but there were no reports of serious injuries or deaths.
ONLY ONE shareholder of the Philippine Dealing System Holdings Corp. (PDSHC) renewed its share purchase agreement (SPA) with the Philippine Stock Exchange, Inc. (PSE), the bourse operator said on Saturday.
14h - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
14h - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...